 | • レポートコード：MRC2312MG12299 • 出版社/出版日：Market Monitor Global / 2023年12月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、119ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医療機器＆消耗品 |
| Single User | ￥471,250 (USD3,250) | ▷ お問い合わせ |
| Enterprise User | ￥706,875 (USD4,875) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査レポートは次の情報を含め、世界のがん再発モニタリングキット市場規模と予測を収録しています。・世界のがん再発モニタリングキット市場：売上、2018年-2023年、2024年-2029年 ・世界のがん再発モニタリングキット市場：販売量、2018年-2023年、2024年-2029年 ・世界のトップ5企業、2022年 世界のがん再発モニタリングキット市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「血液がん」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。 がん再発モニタリングキットのグローバル主要企業は、SeekIn、 Guardant Health、 Neoimmune、 Labcorp Inc、 F.Hoffmann-La Roche Ltd.、 Cergentis B.V.、 Sysmex Corporation、 NeoGenomics Laboratories, Inc.、 Adaptive、 Biotechnologies Corporation、 ArcherDX, Inc.、 Asuragen Inc.、 Arup Laboratories Inc.、 Bio-Rad Laboratories、 Opko Health、 Quest Diagnostics、 ICON plcなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。 MARKET MONITOR GLOBAL（MMG）は、がん再発モニタリングキットのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。 【セグメント別市場分析】 世界のがん再発モニタリングキット市場：タイプ別、2018年-2023年、2024年-2029年 世界のがん再発モニタリングキット市場：タイプ別市場シェア、2022年 ・血液がん、骨がん 世界のがん再発モニタリングキット市場：用途別、2018年-2023年、2024年-2029年 世界のがん再発モニタリングキット市場：用途別市場シェア、2022年 ・病院、診療所 世界のがん再発モニタリングキット市場：地域・国別、2018年-2023年、2024年-2029年 世界のがん再発モニタリングキット市場：地域別市場シェア、2022年 ・北米：アメリカ、カナダ、メキシコ ・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア ・アジア：中国、日本、韓国、東南アジア、インド ・南米：ブラジル、アルゼンチン ・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE 【競合分析】 また、当レポートは主要な市場参加者の分析を提供します。 ・主要企業におけるがん再発モニタリングキットのグローバル売上、2018年-2023年 ・主要企業におけるがん再発モニタリングキットのグローバル売上シェア、2022年 ・主要企業におけるがん再発モニタリングキットのグローバル販売量、2018年-2023年 ・主要企業におけるがん再発モニタリングキットのグローバル販売量シェア、2022年 さらに、当レポートは主要企業のプロファイルを提示します。 SeekIn、 Guardant Health、 Neoimmune、 Labcorp Inc、 F.Hoffmann-La Roche Ltd.、 Cergentis B.V.、 Sysmex Corporation、 NeoGenomics Laboratories, Inc.、 Adaptive、 Biotechnologies Corporation、 ArcherDX, Inc.、 Asuragen Inc.、 Arup Laboratories Inc.、 Bio-Rad Laboratories、 Opko Health、 Quest Diagnostics、 ICON plc ************************************************************* ・調査・分析レポートの概要 がん再発モニタリングキット市場の定義 市場セグメント 世界のがん再発モニタリングキット市場概要 当レポートの特徴・ベネフィット 調査手法と情報源 ・世界のがん再発モニタリングキット市場規模 世界のがん再発モニタリングキット市場規模：2022年 VS 2029年 世界のがん再発モニタリングキット市場規模と予測 2018年-2029年 ・競争状況 グローバルトップ企業 売上ベースでのグローバルトップ企業 企業別グローバルでのがん再発モニタリングキットの売上 グローバルトップ3およびトップ5企業、2022年売上ベース グローバル企業のがん再発モニタリングキット製品タイプ グローバルにおけるティア1、ティア2、ティア3企業 ・タイプ別市場分析 タイプ区分：血液がん、骨がん がん再発モニタリングキットのタイプ別グローバル売上・予測 ・用途別市場分析 用途区分：病院、診療所 がん再発モニタリングキットの用途別グローバル売上・予測 ・地域別市場分析 地域別がん再発モニタリングキット市場規模 2022年と2029年 地域別がん再発モニタリングキット売上・予測 北米市場：アメリカ、カナダ、メキシコ ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア アジア市場：中国、日本、韓国、東南アジア、インド 南米市場：ブラジル、アルゼンチン 中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE ・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど） SeekIn、 Guardant Health、 Neoimmune、 Labcorp Inc、 F.Hoffmann-La Roche Ltd.、 Cergentis B.V.、 Sysmex Corporation、 NeoGenomics Laboratories, Inc.、 Adaptive、 Biotechnologies Corporation、 ArcherDX, Inc.、 Asuragen Inc.、 Arup Laboratories Inc.、 Bio-Rad Laboratories、 Opko Health、 Quest Diagnostics、 ICON plc ... |
This research report provides a comprehensive analysis of the Cancer Recurrence Monitoring Kit market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Cancer Recurrence Monitoring Kit market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Cancer Recurrence Monitoring Kit, challenges faced by the industry, and potential opportunities for market players.
The global Cancer Recurrence Monitoring Kit market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Cancer Recurrence Monitoring Kit market presents opportunities for various stakeholders, including Hospital, Clinic. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Cancer Recurrence Monitoring Kit market. Additionally, the growing consumer demand present avenues for market expansion.
The global Cancer Recurrence Monitoring Kit market was valued at US$ 1433.6 million in 2022 and is projected to reach US$ 3273.9 million by 2029, at a CAGR of 12.6% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Cancer recurrence monitoring kit is one of the important products in the field of medical diagnosis and has a wide market demand. This market prospect continues to grow with increasing number of cancer patients and increasing pursuit of early diagnosis and treatment. The size and growth potential of the market may be affected by a variety of factors, including the increase in cancer patients, technological advancements, improvements in the healthcare system, etc.
Key Features:
The research report on the Cancer Recurrence Monitoring Kit market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Cancer Recurrence Monitoring Kit market.
Market Overview: The report provides a comprehensive overview of the Cancer Recurrence Monitoring Kit market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Blood Cancer, Bone Cancer), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Cancer Recurrence Monitoring Kit market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Cancer Recurrence Monitoring Kit market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Cancer Recurrence Monitoring Kit market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Cancer Recurrence Monitoring Kit market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Cancer Recurrence Monitoring Kit market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Cancer Recurrence Monitoring Kit market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Cancer Recurrence Monitoring Kit, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Cancer Recurrence Monitoring Kit market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Cancer Recurrence Monitoring Kit market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Blood Cancer
Bone Cancer
Market segment by Application
Hospital
Clinic
Global Cancer Recurrence Monitoring Kit Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
SeekIn
Guardant Health
Neoimmune
Labcorp Inc
F.Hoffmann-La Roche Ltd.
Cergentis B.V.
Sysmex Corporation
NeoGenomics Laboratories, Inc.
Adaptive
Biotechnologies Corporation
ArcherDX, Inc.
Asuragen Inc.
Arup Laboratories Inc.
Bio-Rad Laboratories
Opko Health
Quest Diagnostics
ICON plc
Outline of Major Chapters:
Chapter 1: Introduces the definition of Cancer Recurrence Monitoring Kit, market overview.
Chapter 2: Global Cancer Recurrence Monitoring Kit market size in revenue and volume.
Chapter 3: Detailed analysis of Cancer Recurrence Monitoring Kit manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Cancer Recurrence Monitoring Kit in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Cancer Recurrence Monitoring Kit capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Cancer Recurrence Monitoring Kit Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Cancer Recurrence Monitoring Kit Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Cancer Recurrence Monitoring Kit Overall Market Size
2.1 Global Cancer Recurrence Monitoring Kit Market Size: 2022 VS 2029
2.2 Global Cancer Recurrence Monitoring Kit Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Cancer Recurrence Monitoring Kit Sales: 2018-2029
3 Company Landscape
3.1 Top Cancer Recurrence Monitoring Kit Players in Global Market
3.2 Top Global Cancer Recurrence Monitoring Kit Companies Ranked by Revenue
3.3 Global Cancer Recurrence Monitoring Kit Revenue by Companies
3.4 Global Cancer Recurrence Monitoring Kit Sales by Companies
3.5 Global Cancer Recurrence Monitoring Kit Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Cancer Recurrence Monitoring Kit Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Cancer Recurrence Monitoring Kit Product Type
3.8 Tier 1, Tier 2 and Tier 3 Cancer Recurrence Monitoring Kit Players in Global Market
3.8.1 List of Global Tier 1 Cancer Recurrence Monitoring Kit Companies
3.8.2 List of Global Tier 2 and Tier 3 Cancer Recurrence Monitoring Kit Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Cancer Recurrence Monitoring Kit Market Size Markets, 2022 & 2029
4.1.2 Blood Cancer
4.1.3 Bone Cancer
4.2 By Type – Global Cancer Recurrence Monitoring Kit Revenue & Forecasts
4.2.1 By Type – Global Cancer Recurrence Monitoring Kit Revenue, 2018-2023
4.2.2 By Type – Global Cancer Recurrence Monitoring Kit Revenue, 2024-2029
4.2.3 By Type – Global Cancer Recurrence Monitoring Kit Revenue Market Share, 2018-2029
4.3 By Type – Global Cancer Recurrence Monitoring Kit Sales & Forecasts
4.3.1 By Type – Global Cancer Recurrence Monitoring Kit Sales, 2018-2023
4.3.2 By Type – Global Cancer Recurrence Monitoring Kit Sales, 2024-2029
4.3.3 By Type – Global Cancer Recurrence Monitoring Kit Sales Market Share, 2018-2029
4.4 By Type – Global Cancer Recurrence Monitoring Kit Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Cancer Recurrence Monitoring Kit Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Clinic
5.2 By Application – Global Cancer Recurrence Monitoring Kit Revenue & Forecasts
5.2.1 By Application – Global Cancer Recurrence Monitoring Kit Revenue, 2018-2023
5.2.2 By Application – Global Cancer Recurrence Monitoring Kit Revenue, 2024-2029
5.2.3 By Application – Global Cancer Recurrence Monitoring Kit Revenue Market Share, 2018-2029
5.3 By Application – Global Cancer Recurrence Monitoring Kit Sales & Forecasts
5.3.1 By Application – Global Cancer Recurrence Monitoring Kit Sales, 2018-2023
5.3.2 By Application – Global Cancer Recurrence Monitoring Kit Sales, 2024-2029
5.3.3 By Application – Global Cancer Recurrence Monitoring Kit Sales Market Share, 2018-2029
5.4 By Application – Global Cancer Recurrence Monitoring Kit Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Cancer Recurrence Monitoring Kit Market Size, 2022 & 2029
6.2 By Region – Global Cancer Recurrence Monitoring Kit Revenue & Forecasts
6.2.1 By Region – Global Cancer Recurrence Monitoring Kit Revenue, 2018-2023
6.2.2 By Region – Global Cancer Recurrence Monitoring Kit Revenue, 2024-2029
6.2.3 By Region – Global Cancer Recurrence Monitoring Kit Revenue Market Share, 2018-2029
6.3 By Region – Global Cancer Recurrence Monitoring Kit Sales & Forecasts
6.3.1 By Region – Global Cancer Recurrence Monitoring Kit Sales, 2018-2023
6.3.2 By Region – Global Cancer Recurrence Monitoring Kit Sales, 2024-2029
6.3.3 By Region – Global Cancer Recurrence Monitoring Kit Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Cancer Recurrence Monitoring Kit Revenue, 2018-2029
6.4.2 By Country – North America Cancer Recurrence Monitoring Kit Sales, 2018-2029
6.4.3 US Cancer Recurrence Monitoring Kit Market Size, 2018-2029
6.4.4 Canada Cancer Recurrence Monitoring Kit Market Size, 2018-2029
6.4.5 Mexico Cancer Recurrence Monitoring Kit Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Cancer Recurrence Monitoring Kit Revenue, 2018-2029
6.5.2 By Country – Europe Cancer Recurrence Monitoring Kit Sales, 2018-2029
6.5.3 Germany Cancer Recurrence Monitoring Kit Market Size, 2018-2029
6.5.4 France Cancer Recurrence Monitoring Kit Market Size, 2018-2029
6.5.5 U.K. Cancer Recurrence Monitoring Kit Market Size, 2018-2029
6.5.6 Italy Cancer Recurrence Monitoring Kit Market Size, 2018-2029
6.5.7 Russia Cancer Recurrence Monitoring Kit Market Size, 2018-2029
6.5.8 Nordic Countries Cancer Recurrence Monitoring Kit Market Size, 2018-2029
6.5.9 Benelux Cancer Recurrence Monitoring Kit Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Cancer Recurrence Monitoring Kit Revenue, 2018-2029
6.6.2 By Region – Asia Cancer Recurrence Monitoring Kit Sales, 2018-2029
6.6.3 China Cancer Recurrence Monitoring Kit Market Size, 2018-2029
6.6.4 Japan Cancer Recurrence Monitoring Kit Market Size, 2018-2029
6.6.5 South Korea Cancer Recurrence Monitoring Kit Market Size, 2018-2029
6.6.6 Southeast Asia Cancer Recurrence Monitoring Kit Market Size, 2018-2029
6.6.7 India Cancer Recurrence Monitoring Kit Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Cancer Recurrence Monitoring Kit Revenue, 2018-2029
6.7.2 By Country – South America Cancer Recurrence Monitoring Kit Sales, 2018-2029
6.7.3 Brazil Cancer Recurrence Monitoring Kit Market Size, 2018-2029
6.7.4 Argentina Cancer Recurrence Monitoring Kit Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Cancer Recurrence Monitoring Kit Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Cancer Recurrence Monitoring Kit Sales, 2018-2029
6.8.3 Turkey Cancer Recurrence Monitoring Kit Market Size, 2018-2029
6.8.4 Israel Cancer Recurrence Monitoring Kit Market Size, 2018-2029
6.8.5 Saudi Arabia Cancer Recurrence Monitoring Kit Market Size, 2018-2029
6.8.6 UAE Cancer Recurrence Monitoring Kit Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 SeekIn
7.1.1 SeekIn Company Summary
7.1.2 SeekIn Business Overview
7.1.3 SeekIn Cancer Recurrence Monitoring Kit Major Product Offerings
7.1.4 SeekIn Cancer Recurrence Monitoring Kit Sales and Revenue in Global (2018-2023)
7.1.5 SeekIn Key News & Latest Developments
7.2 Guardant Health
7.2.1 Guardant Health Company Summary
7.2.2 Guardant Health Business Overview
7.2.3 Guardant Health Cancer Recurrence Monitoring Kit Major Product Offerings
7.2.4 Guardant Health Cancer Recurrence Monitoring Kit Sales and Revenue in Global (2018-2023)
7.2.5 Guardant Health Key News & Latest Developments
7.3 Neoimmune
7.3.1 Neoimmune Company Summary
7.3.2 Neoimmune Business Overview
7.3.3 Neoimmune Cancer Recurrence Monitoring Kit Major Product Offerings
7.3.4 Neoimmune Cancer Recurrence Monitoring Kit Sales and Revenue in Global (2018-2023)
7.3.5 Neoimmune Key News & Latest Developments
7.4 Labcorp Inc
7.4.1 Labcorp Inc Company Summary
7.4.2 Labcorp Inc Business Overview
7.4.3 Labcorp Inc Cancer Recurrence Monitoring Kit Major Product Offerings
7.4.4 Labcorp Inc Cancer Recurrence Monitoring Kit Sales and Revenue in Global (2018-2023)
7.4.5 Labcorp Inc Key News & Latest Developments
7.5 F.Hoffmann-La Roche Ltd.
7.5.1 F.Hoffmann-La Roche Ltd. Company Summary
7.5.2 F.Hoffmann-La Roche Ltd. Business Overview
7.5.3 F.Hoffmann-La Roche Ltd. Cancer Recurrence Monitoring Kit Major Product Offerings
7.5.4 F.Hoffmann-La Roche Ltd. Cancer Recurrence Monitoring Kit Sales and Revenue in Global (2018-2023)
7.5.5 F.Hoffmann-La Roche Ltd. Key News & Latest Developments
7.6 Cergentis B.V.
7.6.1 Cergentis B.V. Company Summary
7.6.2 Cergentis B.V. Business Overview
7.6.3 Cergentis B.V. Cancer Recurrence Monitoring Kit Major Product Offerings
7.6.4 Cergentis B.V. Cancer Recurrence Monitoring Kit Sales and Revenue in Global (2018-2023)
7.6.5 Cergentis B.V. Key News & Latest Developments
7.7 Sysmex Corporation
7.7.1 Sysmex Corporation Company Summary
7.7.2 Sysmex Corporation Business Overview
7.7.3 Sysmex Corporation Cancer Recurrence Monitoring Kit Major Product Offerings
7.7.4 Sysmex Corporation Cancer Recurrence Monitoring Kit Sales and Revenue in Global (2018-2023)
7.7.5 Sysmex Corporation Key News & Latest Developments
7.8 NeoGenomics Laboratories, Inc.
7.8.1 NeoGenomics Laboratories, Inc. Company Summary
7.8.2 NeoGenomics Laboratories, Inc. Business Overview
7.8.3 NeoGenomics Laboratories, Inc. Cancer Recurrence Monitoring Kit Major Product Offerings
7.8.4 NeoGenomics Laboratories, Inc. Cancer Recurrence Monitoring Kit Sales and Revenue in Global (2018-2023)
7.8.5 NeoGenomics Laboratories, Inc. Key News & Latest Developments
7.9 Adaptive
7.9.1 Adaptive Company Summary
7.9.2 Adaptive Business Overview
7.9.3 Adaptive Cancer Recurrence Monitoring Kit Major Product Offerings
7.9.4 Adaptive Cancer Recurrence Monitoring Kit Sales and Revenue in Global (2018-2023)
7.9.5 Adaptive Key News & Latest Developments
7.10 Biotechnologies Corporation
7.10.1 Biotechnologies Corporation Company Summary
7.10.2 Biotechnologies Corporation Business Overview
7.10.3 Biotechnologies Corporation Cancer Recurrence Monitoring Kit Major Product Offerings
7.10.4 Biotechnologies Corporation Cancer Recurrence Monitoring Kit Sales and Revenue in Global (2018-2023)
7.10.5 Biotechnologies Corporation Key News & Latest Developments
7.11 ArcherDX, Inc.
7.11.1 ArcherDX, Inc. Company Summary
7.11.2 ArcherDX, Inc. Business Overview
7.11.3 ArcherDX, Inc. Cancer Recurrence Monitoring Kit Major Product Offerings
7.11.4 ArcherDX, Inc. Cancer Recurrence Monitoring Kit Sales and Revenue in Global (2018-2023)
7.11.5 ArcherDX, Inc. Key News & Latest Developments
7.12 Asuragen Inc.
7.12.1 Asuragen Inc. Company Summary
7.12.2 Asuragen Inc. Business Overview
7.12.3 Asuragen Inc. Cancer Recurrence Monitoring Kit Major Product Offerings
7.12.4 Asuragen Inc. Cancer Recurrence Monitoring Kit Sales and Revenue in Global (2018-2023)
7.12.5 Asuragen Inc. Key News & Latest Developments
7.13 Arup Laboratories Inc.
7.13.1 Arup Laboratories Inc. Company Summary
7.13.2 Arup Laboratories Inc. Business Overview
7.13.3 Arup Laboratories Inc. Cancer Recurrence Monitoring Kit Major Product Offerings
7.13.4 Arup Laboratories Inc. Cancer Recurrence Monitoring Kit Sales and Revenue in Global (2018-2023)
7.13.5 Arup Laboratories Inc. Key News & Latest Developments
7.14 Bio-Rad Laboratories
7.14.1 Bio-Rad Laboratories Company Summary
7.14.2 Bio-Rad Laboratories Business Overview
7.14.3 Bio-Rad Laboratories Cancer Recurrence Monitoring Kit Major Product Offerings
7.14.4 Bio-Rad Laboratories Cancer Recurrence Monitoring Kit Sales and Revenue in Global (2018-2023)
7.14.5 Bio-Rad Laboratories Key News & Latest Developments
7.15 Opko Health
7.15.1 Opko Health Company Summary
7.15.2 Opko Health Business Overview
7.15.3 Opko Health Cancer Recurrence Monitoring Kit Major Product Offerings
7.15.4 Opko Health Cancer Recurrence Monitoring Kit Sales and Revenue in Global (2018-2023)
7.15.5 Opko Health Key News & Latest Developments
7.16 Quest Diagnostics
7.16.1 Quest Diagnostics Company Summary
7.16.2 Quest Diagnostics Business Overview
7.16.3 Quest Diagnostics Cancer Recurrence Monitoring Kit Major Product Offerings
7.16.4 Quest Diagnostics Cancer Recurrence Monitoring Kit Sales and Revenue in Global (2018-2023)
7.16.5 Quest Diagnostics Key News & Latest Developments
7.17 ICON plc
7.17.1 ICON plc Company Summary
7.17.2 ICON plc Business Overview
7.17.3 ICON plc Cancer Recurrence Monitoring Kit Major Product Offerings
7.17.4 ICON plc Cancer Recurrence Monitoring Kit Sales and Revenue in Global (2018-2023)
7.17.5 ICON plc Key News & Latest Developments
8 Global Cancer Recurrence Monitoring Kit Production Capacity, Analysis
8.1 Global Cancer Recurrence Monitoring Kit Production Capacity, 2018-2029
8.2 Cancer Recurrence Monitoring Kit Production Capacity of Key Manufacturers in Global Market
8.3 Global Cancer Recurrence Monitoring Kit Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Cancer Recurrence Monitoring Kit Supply Chain Analysis
10.1 Cancer Recurrence Monitoring Kit Industry Value Chain
10.2 Cancer Recurrence Monitoring Kit Upstream Market
10.3 Cancer Recurrence Monitoring Kit Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Cancer Recurrence Monitoring Kit Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
| 【がん再発モニタリングキットについて】 がん再発モニタリングキットは、がん患者の治療後にがんの再発を早期に発見することを目的とした医療機器やツールの総称です。これらのキットは、再発の可能性の高い患者の健康状態を定期的に監視するために使用され、効果的な早期対応を可能にするための重要な役割を果たします。 がんの再発は多くの患者にとって大きな不安要素であり、早期に発見することで治療の選択肢が増大し、患者の生存率向上や生活の質の改善に寄与する可能性があります。がん再発モニタリングキットは、血液、尿、さらには組織サンプルを通じて、がん細胞の存在を検出するための手段を提供します。 このキットは、主に血液中のバイオマーカーの測定を基に構成されています。バイオマーカーとは、体内の生理的状態や病理的な変化を反映する物質であり、がんに特有のバイオマーカーを測定することで、再発のリスクを評価することができます。また、これには遺伝子変異や特定のタンパク質の量を測定する手法が含まれます。これにより、患者特有のがんの特性に基づく個別化医療が実現されつつあります。 がん再発モニタリングキットにはいくつかの特徴があります。一つは、非侵襲的な検査を提供する点です。従来の再発検査では画像診断や生検が必要でしたが、非侵襲的な血液検査により、患者への負担を軽減しながら頻繁にチェックが可能になります。また、検査結果が迅速に得られるため、必要に応じた治療法の見直しが素早く行えます。 がん再発モニタリングキットには、いくつかの種類があります。血液検査を用いるものとしては、循環腫瘍細胞（CTC）検出キットや、がん特異的DNA断片を検出する液体生検技術が挙げられます。これらは、体内で新たに生成されたがん細胞から放出された成分を対象としているため、早期に再発の兆候を捉えることができます。加えて、尿検査や組織サンプルを活用した方法も登場しており、各がん種に適した手法が開発されています。 用途としては、主にがん治療後のフォローアップ、再発リスクの評価、予後の予測、さらには治療効果のモニタリングなどが挙げられます。特に、特定の治療が効果的か否かを判断するための指標として非常に有用です。加えて、患者自身が自分のがん状態を把握できることで、精神的な安心感を得ることにもつながります。 関連技術としては、遺伝子解析技術やバイオインフォマティクスが挙げられます。これらの技術は、がん細胞の遺伝子変異や分子の行動を解析するために不可欠であり、新たなバイオマーカーの発見や治療法の開発にも寄与しています。また、人工知能（AI）の技術も進化しており、これによりビッグデータを解析し、より正確な予測モデルを構築することが可能になっています。 がん再発モニタリングキットは、従来の診断方法と比べ、患者中心の医療を実現する大きな可能性を秘めています。非侵襲的な検査方法、迅速な結果取得、個別化医療の実現など、その利点は多岐にわたります。しかし、これらの技術はまだ発展途上であり、正確性や感度をさらに向上させるための研究が求められています。また、倫理的な観点や費用対効果も考慮する必要があり、実臨床でのさらなるデータ蓄積と評価を通じて、これらの技術がもたらす実際の利益を明確にすることが重要です。 今後、がん再発モニタリングキットは、がん治療における重要なツールとして位置づけられることが期待されます。新たなバイオマーカーの発見、新技術の統合、データ解析の進化などを通じて、患者にとって真に価値ある情報を提供できる製品の開発が進むことを期待しています。これにより、がんと闘う全ての患者がより良い未来を切り拓く手助けができることを願っています。 |
